(19)
(11) EP 4 551 242 A2

(12)

(88) Date of publication A3:
22.02.2024

(43) Date of publication:
14.05.2025 Bulletin 2025/20

(21) Application number: 23836159.6

(22) Date of filing: 08.07.2023
(51) International Patent Classification (IPC): 
A61K 38/16(2006.01)
A61K 39/12(2006.01)
C07K 14/025(2006.01)
C07K 19/00(2006.01)
A61P 37/04(2006.01)
A61K 38/17(2006.01)
A61P 31/12(2006.01)
C07K 14/47(2006.01)
A61K 47/62(2017.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/12; A61P 31/20; C12N 2710/20034; A61K 2039/572; A61K 2039/55594; A61K 2039/55505; A61P 35/00; A61K 2039/625; A61K 2039/627; A61K 2039/585
(86) International application number:
PCT/US2023/027186
(87) International publication number:
WO 2024/010962 (11.01.2024 Gazette 2024/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 08.07.2022 US 202263359560 P

(71) Applicants:
  • Poznansky, Mark, C.
    New York, NY 10017 (US)
  • Zook, Anthony
    New York, NY 10017 (US)
  • Zook, Philip
    New York, NY 10017 (US)
  • Gallagher, Patrick
    New York, NY 10017 (US)

(72) Inventors:
  • Poznansky, Mark, C.
    New York, NY 10017 (US)
  • Zook, Anthony
    New York, NY 10017 (US)
  • Zook, Philip
    New York, NY 10017 (US)
  • Gallagher, Patrick
    New York, NY 10017 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) VACCINE INCORPORATING PROTEIN-BASED IMMUNE ADJUVANT